Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO

European Journal of Endocrinology

Volumn 162, Issue 1, 2010, Pages 161-167

  Watt, Torquil ^a,b   Hegedüs, Laszlo ^c   Groenvold, Mogens ^b,d   Bjorner, Jakob Bue ^b,e   Rasmussen, Åse Krogh ^a   Bonnema, Steen Joop ^c   Feldt Rasmussen, Ulla ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d BISPEBJERG HOSPITAL   (Denmark)

^e NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; RADIOACTIVE IODINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CORRELATION COEFFICIENT; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTPARTUM THYROIDITIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SCORING SYSTEM; SUBACUTE THYROIDITIS; TEST RETEST RELIABILITY; THYROID DISEASE; THYROIDECTOMY; TOXIC GOITER; VALIDITY; AGED; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; STANDARD; TREATMENT OUTCOME; VALIDATION STUDY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; THYROID DISEASES; TREATMENT OUTCOME;

EID: 73949160129     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0521     Document Type: Article

References (33)

1. Guyatt GH, Feeny DH & Patrick DL. Measuring health-related quality of life. Annals of Internal Medicine 1993 118 622-629.
2. Sloan JA, Frost MH, Berzon R, Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C & Cella D. The clinical significance of quality of life assessments in oncology: a summary for clinicians. Supportive Care in Cancer 2006 14 988-998.
3. Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM & Selby PJ. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. Journal of Clinical Oncology 2004 22 714-724.
4. Fahrenfort JJ, Wilterdink AM & van der Veen EA. Long-term residual complaints and psychosocial sequelae after remission of hyperthyroidism. Psychoneuroendocrinology 2000 25 201-211.
5. Terwee CB, Gerding MN, Dekker FW, Prummel MF & Wiersinga WM. Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. British Journal of Ophthalmology 1998 82 773-779.
6. Terwee CB, Gerding MN, Dekker FW, Prummel MF, van der Pol JP & Wiersinga WM. Test - retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy. Journal of Clinical Epidemiology 1999 52 875-884.
7. Terwee CB, Dekker FW, Mourits MP, Gerding MN, Baldeschi L, Kalmann R, Prummel MF & Wiersinga WM. Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clinical Endocrinology 2001 54 391-398.
8. Tehrani M, Krummenauer F, Mann WJ, Pitz S, Dick HB & Kahaly GJ. Disease-specific assessment of quality of life after decompression surgery for Graves' ophthalmopathy. European Journal of Ophthalmology 2004 14 193-199.
9. Jaeschke R, Guyatt G, Gerstein H, Patterson C, Molloy W, Cook D, Harper S, Griffith L & Carbotte R. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? Journal of General Internal Medicine 1996 11 744-749.
10. Jaeschke R, Guyatt G, Cook D, Harper S & Gerstein HC. Spectrum of quality of life impairment in hypothyroidism. Quality of Life Research 1994 3 323-327.
11. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R & Dayan CM. Psychologicalwell-being in patients on 'adequate' doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clinical Endocrinology 2002 57 577-585.
12. McMillan CV, Bradley C,Woodcock A, Razvi S &Weaver JU. Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism. Thyroid 2004 14 916-925.
13. Watt T, Groenvold M, Rasmussen AK, Bonnema SJ, Hegedüs L, Bjorner JB & Feldt-Rasmussen U. Quality of life in patients with benign thyroid disorders. A review. European Journal of Endocrinology 2006 154 501-510.
14. Watt T, Hegedüs L, Rasmussen AK, Groenvold M, Bonnema SJ, Bjorner JB & Feldt-Rasmussen U. Which domains of thyroid-related quality of life are most relevant? Patients and clinicians provide complementary perspectives Thyroid 2007 17 647-654.
15. Watt T, Rasmussen AK, Groenvold M, Bjorner JB, Watt SH, Bonnema SJ, Hegedüs L & Feldt-Rasmussen U. Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing. Quality of Life Research 2008 17 1009-1017.
16. Watt T, Bjorner JB, Groenvold M, Rasmussen AK, Bonnema SJ, Hegedüs L & Feldt-Rasmussen U. Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination. Quality of Life Research 2009 18 483-496.
17. Streiner DL & Norman GR. Health measurement scales. In A Practical Guide to their Development and Use, edn 4. Oxford: Oxford University Press, 2008.
18. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. Journal of Clinical Endocrinology and Metabolism 1977 44 203-204.
19. Mourits MP, Prummel MF, Wiersinga WM & Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clinical Endocrinology 1997 47 9-14.
20. Hegedüs L. Thyroid ultrasound. Endocrinology and Metabolism Clinics of North America 2001 30 339-360.
21. Tammemagi MC, Frank JW, Leblanc M, Artsob H & Streiner DL. Methodological issues in assessing reproducibility - a comparative study of various indices of reproducibility applied to repeat ELISA serologic tests for Lyme disease. Journal of Clinical Epidemiology 1995 48 1123-1132.
22. Shrout PE & Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychological Bulletin 1979 86 420-428.
23. Deyo RA, Diehr P & Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Controlled Clinical Trials 1991 12 142S-158S.
24. Fayers PM & Machin D. Quality of Life: Assessment, Analysis and Interpretation Chichester: John Wiley and Sons, 2000.
25. Henderson AR. The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data. Clinica Chimica Acta 2005 359 1-26.
26. Landis JR & Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977 33 159-174.
27. World Health Organization. International Classification of Functioning, Disability, and Health Geneva: World Health Organization, 2001.
28. Wilson IB & Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Journal of the American Medical Association 1995 273 59-65.
29. Nunnally JC & Bernstein I. Psychometric Theory, edn 3. New York: McGraw-Hill, 1994.
30. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB & Jhingran P. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. Journal of Allergy and Clinical Immunology 2006 117 549-556.
31. Miller IW, Epstion NB, Bishop DS & Keitner GI. The McMaster family assessment device: reliability and validity. Journal of Marital and Family Therapy 2009 11 345-356.
32. Biondi B & Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews 2008 29 76-131.
33. Hegedüs L. Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities. Endocrinology and Metabolism Clinics of North America 2009 38 355-371.